WuXi Biologics (Cayman) Inc.

DB:1FW2 Stock Report

Market Cap: €8.9b

WuXi Biologics (Cayman) Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:1FW2 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Nov 24Sell€164,322Weichang ZhouIndividual91,490€1.80
20 Nov 24Sell€533,894Zhisheng ChenIndividual297,258€1.80
24 Jun 24Buy€1,996,407Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany1,445,000€1.38
21 Jun 24Buy€1,395,518Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany1,000,000€1.40
20 Jun 24Buy€285,011Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany200,000€1.43
12 Jun 24Sell€129,686Weichang ZhouIndividual95,919€1.35
12 Jun 24Sell€784,462Zhisheng ChenIndividual580,209€1.35
16 May 24Sell€75,686,286JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany44,283,850€1.71
13 May 24Buy€58,702,955JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany34,381,199€1.71
28 Mar 24Buy€1,364,512Wuxi Biologics Holdings LimitedCompany831,000€1.64
27 Mar 24Buy€399JP Morgan Asset ManagementCompany247€1.62
27 Mar 24Buy€26,672JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany16,500€1.62
27 Mar 24Buy€5,498,819JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,401,667€1.62
27 Mar 24Sell€14,382JP Morgan Asset ManagementCompany8,897€1.62
27 Mar 24Sell€5,658JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,500€1.62
26 Mar 24Sell€8,799,923JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,465,114€1.61
19 Mar 24Sell€29,011,736JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany17,602,783€1.65
15 Mar 24Buy€37,992,716JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany21,989,717€1.73
08 Mar 24Buy€1,703,711JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany831,114€2.05
08 Mar 24Sell€40,041JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany19,533€2.05
08 Mar 24Sell€11,808,560JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,760,518€2.05
06 Mar 24Sell€29,426,947JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany11,851,005€2.48
04 Mar 24Buy€305J.P. Morgan Private Wealth Advisors LLCCompany126€2.42
04 Mar 24Buy€33,915JP Morgan Asset ManagementCompany14,000€2.42
04 Mar 24Buy€65,408JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany27,000€2.42
04 Mar 24Buy€42,709,422JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany17,630,196€2.42
04 Mar 24Sell€35,126JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany14,500€2.42
01 Mar 24Sell€9,171,623JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany4,124,046€2.22
28 Feb 24Buy€12,337,678JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,541,524€2.23
26 Feb 24Sell€41,492,666JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany18,636,736€2.23
02 Feb 24Buy€87,384,688JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany41,742,218€2.09
26 Jan 24Buy€38,094,456BlackRock, Inc.Company10,996,500€3.46
24 Jan 24Buy€17,642,880Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany5,235,500€3.37
23 Jan 24Sell€18,811,436BlackRock, Inc.Company5,595,500€3.36
17 Jan 24Buy€356,720Kenneth Walton HitchnerIndividual100,000€3.57
17 Jan 24Buy€91,808Jackson TaiIndividual25,700€3.57
28 Dec 23Sell€32,636,246JP Morgan Asset ManagementCompany9,870,129€3.31

Insider Trading Volume

Insider Buying: 1FW2 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1FW2?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders14,902,4750.363%
Private Companies584,191,13314.2%
Institutions1,444,819,10535.2%
General Public2,060,681,20250.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 41.82% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.2%
Wuxi Biologics Holdings Limited
584,191,133€1.3b0%no data
4.44%
BlackRock, Inc.
182,282,845€394.1m0.03%0.01%
3.42%
The Vanguard Group, Inc.
140,503,614€303.8m0.51%no data
2.19%
Baillie Gifford & Co.
89,936,386€194.5m-1.26%0.09%
1.64%
Norges Bank Investment Management
67,514,160€146.0m0%0.01%
1.5%
Bosera Asset Management Co., Ltd.
61,567,500€133.1m0%0.59%
1.38%
State Street Global Advisors, Inc.
56,446,260€122.0m0.22%no data
1.36%
GF Fund Management Co., Ltd.
55,921,000€120.9m0%0.24%
1.36%
Schroder Investment Management (Hong Kong) Ltd.
55,708,500€120.4m0%0.7%
1.31%
JP Morgan Asset Management
53,690,945€116.1m0%0.01%
1.22%
JPMorgan Chase & Co, Brokerage and Securities Investments
50,063,659€108.2m0%0.05%
0.98%
Dimensional Fund Advisors LP
40,119,013€86.7m-0.36%0.01%
0.79%
China Asset Management Co. Ltd.
32,498,754€70.3m-0.41%0.07%
0.77%
Zhong Ou Fund Management Co., Ltd
31,689,669€68.5m0%0.26%
0.75%
China Merchants Fund Management Company Ltd.
30,742,086€66.5m0%0.29%
0.71%
UBS Asset Management AG
29,038,611€62.8m14.4%0.01%
0.54%
Franklin Resources, Inc.
22,312,644€48.2m0.36%0.02%
0.53%
Hongde Fund Management Co., Ltd.
21,860,649€47.3m0%1.09%
0.48%
Harvest Fund Management Co. Ltd.
19,505,000€42.2m0%0.09%
0.42%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
17,047,925€36.9m-8.7%0.01%
0.4%
Geode Capital Management, LLC
16,352,676€35.4m-5.91%no data
0.39%
Schroder Investment Management (Singapore) Ltd.
16,043,500€34.7m0%0.21%
0.35%
Zhisheng Chen
14,189,015€30.7m-0.43%no data
0.34%
Amundi Asset Management SAS
13,799,945€29.8m1.38%0.01%
0.32%
Hang Seng Investment Management Limited
13,319,755€28.8m0%0.29%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 13:50
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

WuXi Biologics (Cayman) Inc. is covered by 54 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Linda LuBOCI Research Ltd.
Wai Chak YuenBOCI Research Ltd.
Bo LiBofA Global Research